Notes
Surveillance, Epidemiology, and End Results
Reference
Accordino MK, et al. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer. Journal of Clinical Oncology : 9 May 2016. Available from: URL: http://doi.org/10.1200/JCO.2016.66.6313
Rights and permissions
About this article
Cite this article
Frequent disease monitoring in MBC − no benefit at high cost. PharmacoEcon Outcomes News 754, 14 (2016). https://doi.org/10.1007/s40274-016-3084-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3084-3